Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Metformin: A review of potential mechanism and therapeutic utility beyond diabetes
S Dutta, RB Shah, S Singhal, SB Dutta… - Drug design …, 2023 - Taylor & Francis
Metformin has been designated as one of the most crucial first-line therapeutic agents in the
management of type 2 diabetes mellitus. Primarily being an antihyperglycemic agent …
management of type 2 diabetes mellitus. Primarily being an antihyperglycemic agent …
Molecular mechanisms and signaling pathways involved in sertoli cell proliferation
SB Meroni, MN Galardo, G Rindone, A Gorga… - Frontiers in …, 2019 - frontiersin.org
Sertoli cells are somatic cells present in seminiferous tubules which have essential roles in
regulating spermatogenesis. Considering that each Sertoli cell is able to support a limited …
regulating spermatogenesis. Considering that each Sertoli cell is able to support a limited …
Metformin: A dual-role player in cancer treatment and prevention
MA Galal, M Al-Rimawi, A Hajeer, H Dahman… - International journal of …, 2024 - mdpi.com
Cancer continues to pose a significant global health challenge, as evidenced by the
increasing incidence rates and high mortality rates, despite the advancements made in …
increasing incidence rates and high mortality rates, despite the advancements made in …
Phase II clinical trial of metformin as a cancer stem cell–targeting agent in ovarian cancer
JR Brown, DK Chan, JJ Shank, KA Griffith, H Fan… - JCI …, 2020 - pmc.ncbi.nlm.nih.gov
BACKGROUND Epidemiologic studies suggest that metformin has antitumor effects.
Laboratory studies indicate metformin impacts cancer stem-like cells (CSCs). As part of a …
Laboratory studies indicate metformin impacts cancer stem-like cells (CSCs). As part of a …
Metformin in cancer therapy: a new perspective for an old antidiabetic drug?
I Ben Sahra, Y Le Marchand-Brustel… - Molecular cancer …, 2010 - aacrjournals.org
Metformin is the most widely used antidiabetic drug in the world, and there is increasing
evidence of a potential efficacy of this agent as an anticancer drug. First, epidemiological …
evidence of a potential efficacy of this agent as an anticancer drug. First, epidemiological …
Obesity, type 2 diabetes, and cancer: the insulin and IGF connection
DH Cohen, D LeRoith - Endocrine-related cancer, 2012 - erc.bioscientifica.com
Epidemiological studies suggest a positive association between obesity and type 2 diabetes
mellitus (T2D) with the risk of cancer and cancer-related mortality. Insulin resistance …
mellitus (T2D) with the risk of cancer and cancer-related mortality. Insulin resistance …
Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy
WY Shi, D **ao, L Wang, LH Dong, ZX Yan… - Cell death & …, 2012 - nature.com
Adenosine monophosphate-activated protein kinase (AMPK) acts as a major sensor of
cellular energy status in cancers and is critically involved in cell sensitivity to anticancer …
cellular energy status in cancers and is critically involved in cell sensitivity to anticancer …
Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo
Ovarian cancer is the most lethal gynecologic cancer in women. Its high mortality rate (68%)
reflects the fact that 75% of patients have extensive (> stage III) disease at diagnosis and …
reflects the fact that 75% of patients have extensive (> stage III) disease at diagnosis and …
Metformin inhibits melanoma development through autophagy and apoptosis mechanisms
Metformin is the most widely used antidiabetic drug because of its proven efficacy and
limited secondary effects. Interestingly, recent studies have reported that metformin can …
limited secondary effects. Interestingly, recent studies have reported that metformin can …
Nanoceria: a rare-earth nanoparticle as a novel anti-angiogenic therapeutic agent in ovarian cancer
Ovarian cancer (OvCa) is the fifth most common cause of death from all cancers among
women in United Sates and the leading cause of death from gynecological malignancies …
women in United Sates and the leading cause of death from gynecological malignancies …